Study genes and causes of very short height in children
Part of Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study looks at your child’s growth history and performs genetic testing to better understand why some children are very short. It may help researchers identify possible underlying causes and improve care, using blood samples from the child and both parents.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 4 and 18 years old
- Your child’s height is very low compared to growth charts (about 2.5 standard deviations below average, or a similar target-height measure)
- Your child has had key blood tests for common medical causes and they were normal
- Your child can have additional X-rays and photos taken for study purposes
- You and your child (and both parents) are willing to provide blood samples, and both parents sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether an investigational drug can help children with idiopathic short stature (short height with no known cause) grow taller. It may be an option for children who are very short for their age and have not responded well to standard growth hormone therapy.
This trial tests an investigational drug called GenSci134 for children with idiopathic short stature (short height with no known cause). It aims to see if the drug can help them grow taller. The study is for children who have not been treated with growth hormones before.
This trial tests a medication called vosoritide to see if it can help children with unexplained short stature grow taller. It's for kids who are very short for their age but have normal growth hormone levels and no other known cause.
This study follows children who are short for their age and checks how safe and effective growth hormone is over the long term. It may help families understand expected benefits and side effects for their specific growth-related condition.
This trial tests a weekly growth hormone injection (lonapegsomatropin) compared to the standard daily growth hormone shot in children with short stature due to certain conditions. It aims to see if the weekly shot works as well or better and is safe.
This study is looking for people with rare, unexplained conditions that cause early intellectual disability and low muscle tone. Researchers want to study your cells and blood to try to find new genetic causes that standard DNA tests missed.
Hear when a new Idiopathic Short Stature trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.